TOKSIK MIOKARDIT ASORATLARINI BIOZIKAVIY USULDA OLDINI OLISH CHORALARI

Elmurodova Zarina  Ravshan qizi; Azimov Jurabek Shavkatjon o’g’li; Izzatullayev Javoxirbek  Botirovich; Musayev Hamid Alimardon o’g’li

TOKSIK MIOKARDIT ASORATLARINI BIOZIKAVIY USULDA OLDINI OLISH CHORALARI

Authors

Elmurodova Zarina Ravshan qizi 3st year student of Tashkent Medical Academy, Faculty of Medicine №2
Azimov Jurabek Shavkatjon o’g’li 2st year student of Tashkent Medical Academy, Faculty of Medicine №2
Izzatullayev Javoxirbek Botirovich 2st year student of Tashkent Medical Academy
Musayev Hamid Alimardon o’g’li lecturer of Pathological Physiology at the Tashkent Medical Academy

Keywords:

toksik miokardit, yurak mushagining yallig'lanishi, yurak yetishmovchiligi, yurak aritmiyalari, to'satdan yurak o'limi, toksik ta'sir, oldini olish choralari

Abstract

Toksik miokardit yurak mushagining yallig'lanishi bo'lib, ko'pincha dorilar, zaharli moddalar yoki boshqa toksik ta'sirlarga javoban yuzaga keladi. Ushbu maqolada toksik miokarditning asoratlari va oldini olish choralari haqida so'z boradi. Adabiyotlar tahlili asosida toksik miokarditning etiologiyasi, patogenezi, klinik belgilari, tashxis usullari va davolash tamoyillari yoritilgan. Shuningdek, kasallikning asoratlari, jumladan, o'tkir yurak yetishmovchiligi, yurak aritmiyalari va to'satdan yurak o'limining oldini olish choralari muhokama qilingan. Maqolada toksik miokarditni erta aniqlash, o'z vaqtida davolashni boshlash va yurakni toksik ta'sirlardan himoya qilishning ahamiyati ta'kidlangan.

References

Kindermann, I., et al., Myocarditis: from bench to bedside. European Heart Journal, 2012. 33(22): p. 2785-2796. [15]

Sagar, S., P.P. Liu, and L.T. Cooper Jr, Myocarditis. The Lancet, 2012. 379(9817): p. 738-747. [16]

Caforio, A.L., et al., Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal, 2013. 34(33): p. 2636-2648. [17]

Briasoulis, A., et al., Inpatient Outcomes of Adult Patients with Myocarditis. American Journal of Cardiology, 2021. 145: p. 135-137. [18]

Kearney, M.T., et al., Myocarditis and dilated cardiomyopathy: a review for the clinician. British Journal of Clinical Pharmacology, 2001. 52(5): p. 439-452. [19]

Baughman, K.L., Diagnosis of myocarditis: death of Dallas criteria. Circulation, 2006. 113(4): p. 593-595. [20]

Felker, G.M., et al., Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. New England Journal of Medicine, 2000. 342(15): p. 1077-1084. [21]

Cooper, L.T., Myocarditis. New England Journal of Medicine, 2009. 360(15): p. 1526-1538. [22]

Maron, B.J., et al., Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation, 2009. 119(8): p. 1085-1092. [23]

Brambatti, M., et al., Fulminant myocarditis: characteristics, treatment, and outcomes. Anatolian journal of cardiology, 2015. 15(4): p. 281-286. [24]

McCarthy III, R.E., et al., Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. New England Journal of Medicine, 2000. 342(10): p. 690-695. [25]

Hung, M.-J., et al., Arrhythmias in viral myocarditis: Focus on inflammatory infiltrates. International journal of cardiology, 2006. 113(1): p. 130-131. [26]

Baksi, A.J., et al., Atrial fibrillation in myocarditis: A systematic review. International Journal of Cardiology, 2015. 187: p. 325-333. [27]

Pieroni, M., et al., Myocarditis in patients with COVID-19: a systematic review of published cases. Revista Española de Cardiología, 2021. 74(5): p. 466

TOKSIK MIOKARDIT ASORATLARINI BIOZIKAVIY USULDA OLDINI OLISH CHORALARI